Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:7282
TSE:7282Auto Components

Toyoda Gosei (TSE:7282) Valuation Check After Strong Earnings Dividend Increase And New Guidance

Toyoda Gosei (TSE:7282) is back in focus after its board approved a higher year end dividend, released full year 2026 results, and outlined new earnings guidance alongside an upcoming stock split. See our latest analysis for Toyoda Gosei. The stock has been volatile, with a 12.24% 1 month share price return and a 14.33% year to date share price return. The 1 year total shareholder return of 75.60% points to strong momentum around the latest earnings and dividend news. If Toyoda Gosei’s move...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

Is It Too Late To Consider J.B. Hunt Transport Services (JBHT) After Its 78% One Year Rally?

Investors may be wondering if J.B. Hunt Transport Services at around US$242 per share is still offering value, or if most of the opportunity is already priced in. The stock has been volatile in the short term, with a 3.7% decline over the last 7 days. However, returns of 11.2% over 30 days, 23.1% year to date, and 78.1% over the last year may have changed how investors view its risk and reward profile. Recent coverage has focused on J.B. Hunt Transport Services as a large US transportation...
NYSE:PFE
NYSE:PFEPharmaceuticals

Assessing Pfizer’s (PFE) Valuation As Shares Hover Near Recent Levels

Why Pfizer (PFE) is on investors’ radar today Pfizer (PFE) is back in focus after recent trading left the stock around $26.48. This has prompted investors to reassess how its current valuation lines up with its large global biopharma portfolio and earnings profile. See our latest analysis for Pfizer. Recent trading has been slightly soft, with a 30 day share price return of 2.29% and a 90 day share price return of 2.72%. However, the 1 year total shareholder return of 25.69% points to...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Guardant Health (GH) Valuation Check After FDA Approval For Guardant360 CDx In ESR1 Mutated Breast Cancer

Guardant Health (GH) is back in focus after the U.S. Food and Drug Administration approved its Guardant360 CDx liquid biopsy as a companion diagnostic for VEPPANU in ESR1 mutated advanced breast cancer. See our latest analysis for Guardant Health. Guardant Health’s latest FDA approval comes on the heels of a series of events, including a multi year collaboration with Nuvalent and first quarter results that paired higher sales with a wider net loss. It also follows a period where the share...
NYSE:TSM
NYSE:TSMSemiconductor

TSMC Wind Deal Brings 2040 Renewables Goal And Valuation Into Focus

Taiwan Semiconductor Manufacturing (NYSE:TSM) has signed a 30 year power purchase agreement for the full capacity of a major Taiwanese offshore wind project. The company now aims to use 100% renewable energy by 2040, bringing its prior target forward by ten years. This agreement is described as the largest offshore wind PPA of its kind in Asia and expands TSMC's overall sustainability ambitions. TSMC, trading at $414.15, has delivered a 4.6% return over the past week and 19.9% over the past...
NYSE:HNI
NYSE:HNICommercial Services

Brim Chair Launch Highlights HNI Product Refresh And Valuation Opportunity

HON Company, a subsidiary of NYSE:HNI, has introduced Brim, a design-focused office chair centered on comfort, versatility, and contemporary aesthetics. Brim is the result of a collaboration with designer Nils Koehn and is scheduled to debut at a major industry event. The launch adds a new product to HNI's office furniture portfolio that targets modern workspaces and workplace transformation themes. For investors following NYSE:HNI, Brim arrives in a segment where office furniture suppliers...
XTRA:MZX
XTRA:MZXMachinery

Masterflex (XTRA:MZX) Q1 EPS Rebound Challenges Bearish Earnings Slowdown Narratives

Masterflex (XTRA:MZX) has opened 2026 with Q1 revenue of €27.673 million and basic EPS of €0.33, setting the tone for how the rest of the year could shape up. Over recent quarters, the company has seen revenue move between €21.151 million in Q4 2024 and €27.673 million in Q1 2026, while quarterly EPS has ranged from €0.10 in Q4 2025 to €0.33 in Q1 2026. This gives investors a clear view of how the top line and EPS have tracked through the cycle. With trailing 12 month net income of €8.823...
NasdaqGS:KELY.A
NasdaqGS:KELY.AProfessional Services

Kelly Services (KELY.A) Posts Smaller Q1 Loss Challenging Bullish Margin Expansion Narrative

Kelly Services (KELY.A) has opened 2026 with Q1 revenue of US$1.0 billion and a basic EPS loss of US$0.17, alongside a net loss of US$5.9 million, putting the focus squarely on how quickly profitability can stabilise. Over recent quarters, revenue has moved from US$1.16 billion in Q1 2025 to US$1.04 billion in Q4 2025 and US$1.04 billion in Q1 2026. EPS has swung from a Q1 2025 profit of US$0.16 to losses of US$3.69 in Q4 2025 and US$0.17 in the latest quarter, leaving investors weighing...
NYSE:O
NYSE:ORetail REITs

Is Realty Income (O) Offering A Compelling Entry Point After Recent Share Price Pullback

For investors wondering if Realty Income at around US$61.79 is offering fair value or a better entry point today, this article breaks down what the current price may be implying about the stock. The stock has returned 7.8% year to date and 16.0% over the last year, despite a 3.8% decline over the past week and a 0.7% slip over the past month. Recent coverage has focused on Realty Income's position as a large retail REIT and its role as a regular dividend payer. This often puts extra...
NYSE:MET
NYSE:METInsurance

MetLife (MET) Q1 2026 Margin Compression Challenges Bullish Earnings Growth Narrative

MetLife (MET) has opened 2026 with Q1 revenue of about US$19.1b and basic EPS of US$1.74, setting a clear yardstick for how its profitability is tracking against prior periods. Over recent quarters the company has seen revenue move between roughly US$17.3b and US$23.8b, while basic EPS has ranged from about US$1.04 to US$1.79. This gives you a fuller sense of how this latest print sits within its recent earnings rhythm. With trailing 12 month margins softer than a year ago, this quarter’s...
NYSE:JMIA
NYSE:JMIAMultiline Retail

Is Jumia (JMIA) Prioritizing Scale Over Profitability As Q1 2026 Loss Widens With Sales Growth?

Jumia Technologies AG has released its Q1 2026 results, reporting sales of US$50.56 million versus US$36.26 million a year earlier, alongside a net loss of US$17.73 million compared with US$16.71 million previously. The combination of faster sales growth and a slightly wider loss in the latest quarter gives investors fresh insight into how Jumia is balancing expansion with cost control. We’ll now explore how Jumia’s strong year-on-year sales increase, despite a wider quarterly loss, reshapes...
NYSE:EVH
NYSE:EVHHealthcare Services

Evolent Health (EVH) Narrows Q1 Loss To US$26.6 Million Testing Bullish Margin Narratives

Evolent Health (EVH) opened Q1 2026 with revenue of US$496.2 million, a basic EPS loss of US$0.24, and a net income loss of US$26.6 million, setting a clear tone for another quarter where growth and profitability are pulling in different directions. The company reported quarterly revenue of US$483.6 million in Q1 2025 and US$496.2 million in Q1 2026, while basic EPS over that span ranged from a loss of US$0.63 in Q1 2025 to a loss of US$0.24 in the latest quarter. This frames a results season...
NYSE:CL
NYSE:CLHousehold Products

Colgate-Palmolive (CL) Valuation Check After Q1 Earnings Beat And Reaffirmed Sales Guidance

Colgate-Palmolive (CL) has drawn fresh investor attention after reporting first quarter 2026 results that exceeded earnings expectations and reaffirming guidance for 2% to 6% net sales growth for the full year. See our latest analysis for Colgate-Palmolive. The stock has gained 5.09% on a 30 day share price return and 12.45% year to date, while the 1 year total shareholder return of a 1.39% decline suggests recent momentum contrasts with a softer longer term outcome. If Colgate-Palmolive's...
NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

StoneX Group (SNEX) Earnings Growth On 0.3% Margin Tests Bullish Profitability Narratives

StoneX Group (SNEX) opened Q2 2026 with total revenue of about US$45.3b, basic EPS of US$2.21, and net income of US$168.9m, setting a clear marker for its latest quarter. Over the past six quarters, the company has seen revenue move from US$27.6b in Q1 2025 to US$45.3b in Q2 2026, while quarterly basic EPS shifted from US$1.18 to US$2.21 and net income from US$82.4m to US$168.9m, with trailing twelve month EPS at US$6.01 and net income at US$446.8m. For investors, the combination of these...
BIT:IVG
BIT:IVGMachinery

Iveco Group Q1 Loss Challenges Bullish Margin Recovery Narrative

Iveco Group (BIT:IVG) has kicked off Q1 2026 with revenue of €2.8b and a basic EPS loss of €0.44, alongside net income from continuing operations of a €117m loss. Over recent quarters the company has seen revenue move from €4.0b in Q4 2025 to €2.8b in Q1 2026, while basic EPS shifted from €0.47 in Q4 2025 to a loss of €0.44 in Q1 2026. This sets the scene for a results season where growth forecasts sit beside tight margins and a close watch on profitability trends. See our full analysis for...
NasdaqGS:PWP
NasdaqGS:PWPCapital Markets

A Look At Perella Weinberg Partners (PWP) Valuation After Weak First Quarter 2026 Earnings

Perella Weinberg Partners (PWP) has come under closer scrutiny after first quarter 2026 earnings reported net income of US$1.49 million and earnings per share of US$0.02, along with continued dividend payments. See our latest analysis for Perella Weinberg Partners. The recent 17.19% 7-day share price decline and 19.05% 90-day share price drop suggest sentiment has cooled after weaker first quarter results. However, a 7.29% year-to-date share price return and very large 3-year total...
ASX:PLS
ASX:PLSMetals and Mining

Does PLS Group’s (ASX:PLS) Brazil Push Recast Its Risk Profile More Than Its Growth Story?

In early May 2026, PLS Group updated investors on its Pilgangoora Operation and broader business, stressing that production, cost and resource estimates remain inherently uncertain and urging stakeholders to recognize the speculative nature of its securities. At the same time, the company outlined significant expansion projects in Australia and Brazil that, alongside its disciplined growth approach, aim to reinforce its position as a major global lithium producer amid strong demand linked...
NYSE:KKR
NYSE:KKRCapital Markets

Assessing KKR’s (KKR) Valuation After Mixed Short Term Returns And Strong Three Year Gains

What KKR’s Recent Performance Signals for Investors KKR (KKR) has drawn investor attention after a recent stretch of mixed returns, with the stock up over the past month but lower over the past 3 months and year to date. See our latest analysis for KKR. The recent 10.57% 1 month share price return contrasts with a 22.16% share price decline year to date, while the 3 year total shareholder return of 111.06% shows how strong longer term holders have fared. If KKR’s swings have you thinking...
NYSE:KNTK
NYSE:KNTKOil and Gas

Kinetik Holdings (KNTK) Q1 EPS Loss Tests Bullish Profitability Narratives

Kinetik Holdings (KNTK) opened 2026 with Q1 revenue of US$410 million and a basic EPS loss of US$0.03, setting a very different tone from the strong profitability that shows up in its trailing numbers. Over the past year, revenue on a trailing basis has sat around US$1.7 billion with basic EPS of US$2.48, up from trailing revenue of about US$1.5 billion and EPS of US$1.03 a year earlier as earnings jumped 176.8% and margins improved from 3.6% to 9.1%. For investors, this mix of a soft...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Workday Faces Governance Demands As Healthcare Partnership And Valuation Draw Focus

Shareholder activists and major institutional investors have submitted proposals for Workday's 2026 annual meeting seeking more detail on share class voting rights and employee retention disclosures. Advocacy groups are also asking for granular reporting on workforce diversity metrics, increasing pressure on Workday to expand its governance and transparency practices. At the same time, Workday announced a new integration partnership with QGenda to connect its platform more closely with...
NasdaqGS:BLLN
NasdaqGS:BLLNHealthcare

BillionToOne (BLLN) Q1 EPS Swing To US$0.39 Tests Confidence In Bullish Profitability Narrative

BillionToOne (BLLN) opened Q1 2026 with revenue of $108.4 million and Basic EPS of $0.39, putting fresh numbers on the table for investors tracking its recent move into profitability. The company reported quarterly revenue of $59.0 million in Q1 2025 and $108.4 million in Q1 2026, while Basic EPS moved from a loss of $0.39 to a profit of $0.39 over the same period. This sets up a clear contrast in how the income statement now converts sales into earnings. Overall, margins appear firmer and...
NasdaqGS:ROOT
NasdaqGS:ROOTInsurance

Root (ROOT) Q1 Net Income Surge Tests Bearish Earnings Decline Narrative

Root (ROOT) opened Q1 2026 with total revenue of US$393.5 million and basic EPS of US$2.19, alongside net income of US$34.2 million, setting a clear earnings marker for investors watching the stock at around US$56.91. Over the past year, the company has reported revenue of US$326.7 million in Q4 2024 and US$393.5 million in the latest quarter, while trailing twelve month EPS is US$3.55 on net income of US$55 million, giving a fuller picture of how profits have stacked up through recent...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Payoneer Global (PAYO) Margin Compression Challenges Bullish Earnings Growth Narratives

Payoneer Global (PAYO) opened 2026 with Q1 revenue of US$261.6 million and basic EPS of US$0.057, alongside net income of US$19.6 million. This framed a quarter where profitability held steady in absolute terms. Over the last year, the company has seen trailing twelve month revenue move from US$977.7 million to US$1.07 billion, while basic EPS on the same basis sits at about US$0.20 and net income stands at US$72.2 million. This provides a clearer view of the earnings run rate behind the...